This country profile provides an overview of the Congo’s progress in reaching those in need of mass NTD treatment based on 2016 data.

NTD mass treatment coverage index: 16/100
Overall rank: Joint 28th

Treatment coverage

Lymphatic filariasis
12%
Onchocerciasis
79%
Schistosomiasis
25%
STH
3%
Trachoma
N/A
473,000 people received treatment in the Congo in 2016 1.8 million people in need did not receive treatment in the Congo in 2016

Congo recommendations

These recommendations were given to heads of state at the African Union summit in January 2017 as part of the ALMA Scorecard for Accountability and Action.

  • Work to return the preventive chemotherapy coverage levels to those achieved in 2015. Start elimination mapping and impact assessments for onchocerciasis.
  • Increase budget allocation for neglected tropical diseases at the national level.
  • Provide timely data to the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) to enable monitoring and planning.

Lymphatic filariasis

⬆️ Treatment coverage slightly increased from 11% in 2015 to 12% in 2016.

People needing treatment
963,000
People receiving treatment
112,000

Onchocerciasis

⬆️ Treatment coverage slightly increased from 78% in 2015 to 79% in 2016.

People needing treatment
597,000
People receiving treatment
473,000

Schistosomiasis

⬇️ Treatment coverage decreased from 100% in 2015 to 25% in 2016.

School-aged children needing treatment
69,000
School-aged children receiving treatment
17,000

Soil-transmitted helminths

⬇️ Treatment coverage decreased from 28% in 2015 to 3% in 2016.

Pre-sch and school-aged children needing treatment
1.69m
Pre-school and school-aged children receiving treatment
50,000

Trachoma

Congo does not require mass treatment for trachoma.